Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 25, 2025 07:30 ET | Source: MannKind

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
August 11, 2025 09:00 ET | Source: XOMA Royalty Corporation

XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics

XOMA Royalty closes tender offer for Turnstone Biologics.
August 11, 2025 06:01 ET | Source: Zeo Energy Corp.

Zeo Energy Corp. Completes Acquisition of Heliogen, Inc.

NEW PORT RICHEY, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a leading Florida-based provider of residential solar and energy...
August 05, 2025 08:30 ET | Source: Y-mAbs Therapeutics, Inc.

SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics

Acquisition to Include DANYELZA® (Naxitamab-gqgk), Further Broadening SERB’s Rare Oncology Product PortfolioTransaction Expands SERB’s Investment in the U.S.SERB to Commence All-Cash Tender Offer to...
August 04, 2025 07:30 ET | Source: XOMA Royalty Corporation; LAVA Therapeutics N.V.

XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

XOMA Royalty to Acquire LAVA for between $1.16 and $1.24 per share in cash plus a CVR.
July 29, 2025 07:36 ET | Source: ZOOZ Power Ltd

ZOOZ Announces Private Placement of $180 Million to Launch a Bitcoin Treasury Reserve Strategy

ZOOZ to become the first Nasdaq and TASE dual-listed company to hold Bitcoin in its treasury The Board of Directors of the Company has approved the new strategy, which provides investors with...
July 25, 2025 11:00 ET | Source: Ikena Oncology, Inc.

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on Monday, July 28, 2025 ImageneBio, Inc. will...
July 25, 2025 11:00 ET | Source: ImageneBio, Inc.

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol “IMA” at market open on Monday, July 28, 2025 ImageneBio, Inc. will...
July 22, 2025 08:00 ET | Source: Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals Secures $500 Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH

Proceeds to primarily support MASH pipeline expansion and to refinance existing senior credit facility$350 million initial term loan funded at close and up to an additional $150 million available...
June 30, 2025 16:17 ET | Source: PlayAGS, Inc.

Brightstar Capital Partners Completes Acquisition of PlayAGS for Approximately $1.1 Billion Dollars

LAS VEGAS and NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Brightstar Capital Partners (“Brightstar”), a private equity firm focused on investing in business services, industrials, consumer, and...